WGRX News

Wellgistics Health firma una carta de intención para evaluar la posible adquisición de Neuritek Therapeutics

Wellgistics Health Inc.签署1.05亿美元意向书，拟评估收购Neuritek Therapeutics, Inc.的可行性，后者致力于开发神经系统及精神疾病的创新疗法

Wellgistics Management Converts $2 Million in Deferred Compensation into Equity at $0.20 per Share

Wellgistics President Releases Letter to Shareholder on Emerging Patient Care-Centric Strategic Direction

Form 8-K

Wellgistics Strengthens PharmacyChain(TM) with Insurance Eligibility & Benefits Verification Capabilities

Form 8-K

Wellgistics Targets $70B Market Breakthrough Addressing Ozempic / GLP-1 Muscle Loss with Forzet(TM)

Wellgistics Health Selects Top Five Blockchain Platforms to Initiate Patent Protected PharmacyChain(TM) Smart Contracts-enabled Pharmaceutical Drug Tracking System to Support Industry-wide Serialization Mandate

DataVault AI and Wellgistics Health Announce Plans to Expand Partnership to Include Healthcare Delivery Intellectual Property for Healthcare as a Service (HaaS) Blockchain-enabled Smart Contracts